Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
Authors
Keywords
Malignant melanoma, Metformin, Pembrolizumab, Ipilimumab, Nivolumab, Anti-PD-1/anti-CTLA-4
Journal
Journal for ImmunoTherapy of Cancer
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-02
DOI
10.1186/s40425-018-0375-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma
- (2017) Sun Hye Kim et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Metformin monotherapy in melanoma: a pilot, open-label, prospective, and multicentric study indicates no benefit
- (2017) Henri Montaudié et al. Pigment Cell & Melanoma Research
- Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma
- (2016) Jarrett J. Failing et al. MELANOMA RESEARCH
- Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
- (2016) Nicole E. Scharping et al. Cancer Immunology Research
- Optimal therapy of type 2 diabetes: a controversial challenge
- (2016) Angela Dardano et al. Aging-US
- Combining BRAFV600Einhibition with modulators of the mitochondrial bioenergy metabolism to overcome drug resistance in metastatic melanoma
- (2015) Elisabeth Livingstone et al. EXPERIMENTAL DERMATOLOGY
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
- (2015) Douglas Marvel et al. JOURNAL OF CLINICAL INVESTIGATION
- Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies
- (2015) D. B. Johnson et al. Cancer Immunology Research
- Is it time to test biguanide metformin in the treatment of melanoma?
- (2014) Michael Cerezo et al. Pigment Cell & Melanoma Research
- Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
- (2013) M. Cerezo et al. MOLECULAR CANCER THERAPEUTICS
- Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
- (2013) Monica Franciosi et al. PLoS One
- Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
- (2012) Chang W. Song et al. Scientific Reports
- Mechanisms of Resistance to RAF Inhibitors in Melanoma
- (2011) Andrew E. Aplin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
- (2011) T Tomic et al. Cell Death & Disease
- Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
- (2010) Carolyn Algire et al. ENDOCRINE-RELATED CANCER
- Epithelial–mesenchymal transition in the skin
- (2010) Motonobu Nakamura et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
- (2010) I. Ben Sahra et al. MOLECULAR CANCER THERAPEUTICS
- 32 INVITED New response evaluation criteria in solid tumors: revised RECIST guideline version 1.1
- (2008) E. Eisenhauer et al. EJC SUPPLEMENTS
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation